160 related articles for article (PubMed ID: 6979509)
1. Role of H-2 antigens in the host response to methylcholanthrene-induced tumors.
Ahrlund-Richter L; Klein E; Merino F
Immunogenetics; 1982 Jan; 15(1):53-62. PubMed ID: 6979509
[TBL] [Abstract][Full Text] [Related]
2. Are methylcholanthrene-induced sarcoma-associated, rejection-inducing (TSTA) antigens, modified forms of H-2 or linked determinants?
Klein G; Klein E
Int J Cancer; 1975 Jun; 15(6):879-87. PubMed ID: 50291
[TBL] [Abstract][Full Text] [Related]
3. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
[TBL] [Abstract][Full Text] [Related]
4. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection.
Leffell MS; Coggin JH
Cancer Res; 1977 Nov; 37(11):4112-9. PubMed ID: 908044
[No Abstract] [Full Text] [Related]
5. Tumor-associated antigens in isoantigenic variants of a 3-methylcholanthrene-induced sarcoma.
Oth D; Berebbi M; Meyer G
J Natl Cancer Inst; 1975 Oct; 55(4):903-8. PubMed ID: 52721
[TBL] [Abstract][Full Text] [Related]
6. Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens.
Dudley ME; Roopenian DC
J Exp Med; 1996 Aug; 184(2):441-7. PubMed ID: 8760797
[TBL] [Abstract][Full Text] [Related]
7. Changes in tumor-specific antigen expression during passage in vitro and in vivo of newly derived methylcholanthrene-induced sarcomas of BALB/C mice.
Law LW
Int J Cancer; 1980 Feb; 25(2):251-9. PubMed ID: 6156130
[TBL] [Abstract][Full Text] [Related]
8. The roles of two peritoneal T-lymphocyte populations in the in vivo rejection of methylcolanthrene-induced sarcoma.
Kadhim SA; Rees RC; Barrington-Leigh J
Cell Immunol; 1985 Jan; 90(1):234-41. PubMed ID: 2578328
[TBL] [Abstract][Full Text] [Related]
9. The Lyt phenotype of the T cells in an antitumor adoptive transfer differs for "parent to F1" and "parent to parent" combinations.
Ahrlund-Richter L; Wikström AC; Ramqvist T; Klein E
Cell Immunol; 1984 Jul; 86(2):575-82. PubMed ID: 6610486
[TBL] [Abstract][Full Text] [Related]
10. Unique and common tumor-specific transplantation antigens of chemically induced mouse sarcomas.
Hellström KE; Hellström I; Brown JP
Int J Cancer; 1978 Mar; 21(3):317-22. PubMed ID: 75855
[TBL] [Abstract][Full Text] [Related]
11. Alien histocompatibility determinants on the cell surface of sarcomas induced by methylcholanthrene. I. In vivo studies.
Parmiani G; Invernizzi G
Int J Cancer; 1975 Nov; 16(5):756-67. PubMed ID: 52628
[TBL] [Abstract][Full Text] [Related]
12. Comparison of tumor-associated transplantation antigens of sublines of methylcholanthrene-induced murine tumors passaged separately in vivo for over a decade.
Hines DL
Cancer Res; 1986 Oct; 46(10):4921-6. PubMed ID: 3489516
[TBL] [Abstract][Full Text] [Related]
13. Tumor-associated antigens in H-2 hemizygous isoantigenic variants of a somatic cell hybrid, derived from the fusion of a 3-methylcholanthrene-induced sarcoma and a mammary carcinoma.
Klein G
J Natl Cancer Inst; 1977 Feb; 58(2):383-6. PubMed ID: 833884
[TBL] [Abstract][Full Text] [Related]
14. Immunochemical characterization of foreign H-2-like antigens expressed by a methyl-cholanthrene-induced sarcoma.
García-Olivares E; Gutierrez F; Osorio C
Ann Immunol (Paris); 1982; 133C(3):377-81. PubMed ID: 7149645
[No Abstract] [Full Text] [Related]
15. Expression of alien minor histocompatibility antigens distinct from tumor-specific transplantation antigen on a murine fibrosarcoma.
Parmiani G; Colombo M; Ballinari D
Int J Cancer; 1980 Oct; 26(4):461-5. PubMed ID: 7251224
[TBL] [Abstract][Full Text] [Related]
16. Lack of identity between TSTA and alien antigens of methylcholanthrene-induced murine sarcomas.
Parmiani G
Transplant Proc; 1980 Mar; 12(1):50-2. PubMed ID: 7368293
[No Abstract] [Full Text] [Related]
17. Inhibition of the induction of contrasuppression by antisera against tumor-associated surface antigens on methylcholanthrene-induced sarcomas.
Flood PM; DeLeo AB; Old LJ; Gershon RK
Haematol Blood Transfus; 1983; 28():486-8. PubMed ID: 6222948
[No Abstract] [Full Text] [Related]
18. Phenotypes associated with tumor rejection mediated by cyclophosphamide and syngeneic tumor-sensitized T lymphocytes: potential mechanisms of action.
Evans R
Int J Cancer; 1984 Mar; 33(3):381-8. PubMed ID: 6607893
[TBL] [Abstract][Full Text] [Related]
19. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and incompatible tumor cells.
Klein E; Klein G
Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5056574
[No Abstract] [Full Text] [Related]
20. Biological and biochemical properties of Nonidet P40-solubilized and partially purified tumor-specific antigens of the transplantation type from plasma membranes of a methylcholanthrene-induced sarcoma.
Natori T; Law LW; Appella E
Cancer Res; 1977 Sep; 37(9):3406-13. PubMed ID: 69494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
